CPMV
Price
$0.77
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
5.57M
PPTDF
Price
$11.81
Change
+$0.81 (+7.36%)
Updated
Sep 16 closing price
Capitalization
1.41B
Interact to see
Advertisement

CPMV vs PPTDF

Header iconCPMV vs PPTDF Comparison
Open Charts CPMV vs PPTDFBanner chart's image
Mosaic ImmunoEngineering
Price$0.77
Change-$0.00 (-0.00%)
Volume$1K
Capitalization5.57M
Peptidream
Price$11.81
Change+$0.81 (+7.36%)
Volume$1.3K
Capitalization1.41B
CPMV vs PPTDF Comparison Chart in %
Loading...
CPMV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPMV vs. PPTDF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPMV is a Hold and PPTDF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CPMV: $0.77 vs. PPTDF: $11.81)
Brand notoriety: CPMV and PPTDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPMV: 98% vs. PPTDF: 117%
Market capitalization -- CPMV: $5.57M vs. PPTDF: $1.41B
CPMV [@Biotechnology] is valued at $5.57M. PPTDF’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPMV’s FA Score shows that 0 FA rating(s) are green whilePPTDF’s FA Score has 0 green FA rating(s).

  • CPMV’s FA Score: 0 green, 5 red.
  • PPTDF’s FA Score: 0 green, 5 red.
According to our system of comparison, CPMV is a better buy in the long-term than PPTDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPMV’s TA Score shows that 5 TA indicator(s) are bullish while PPTDF’s TA Score has 3 bullish TA indicator(s).

  • CPMV’s TA Score: 5 bullish, 4 bearish.
  • PPTDF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, CPMV is a better buy in the short-term than PPTDF.

Price Growth

CPMV (@Biotechnology) experienced а +9.83% price change this week, while PPTDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PPTDF($1.41B) has a higher market cap than CPMV($5.57M). CPMV YTD gains are higher at: 9.641 vs. PPTDF (-33.838). CPMV has higher annual earnings (EBITDA): -604.21K vs. PPTDF (-3.66B). PPTDF has more cash in the bank: 33.3B vs. CPMV (53.6K). CPMV has less debt than PPTDF: CPMV (1.63M) vs PPTDF (18.3B). PPTDF has higher revenues than CPMV: PPTDF (19.1B) vs CPMV (0).
CPMVPPTDFCPMV / PPTDF
Capitalization5.57M1.41B0%
EBITDA-604.21K-3.66B0%
Gain YTD9.641-33.838-28%
P/E RatioN/A14.62-
Revenue019.1B-
Total Cash53.6K33.3B0%
Total Debt1.63M18.3B0%
FUNDAMENTALS RATINGS
CPMV vs PPTDF: Fundamental Ratings
CPMV
PPTDF
OUTLOOK RATING
1..100
8230
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4263
P/E GROWTH RATING
1..100
53100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CPMV's Valuation (80) in the null industry is in the same range as PPTDF (88). This means that CPMV’s stock grew similarly to PPTDF’s over the last 12 months.

CPMV's Profit vs Risk Rating (100) in the null industry is in the same range as PPTDF (100). This means that CPMV’s stock grew similarly to PPTDF’s over the last 12 months.

PPTDF's SMR Rating (98) in the null industry is in the same range as CPMV (100). This means that PPTDF’s stock grew similarly to CPMV’s over the last 12 months.

CPMV's Price Growth Rating (42) in the null industry is in the same range as PPTDF (63). This means that CPMV’s stock grew similarly to PPTDF’s over the last 12 months.

CPMV's P/E Growth Rating (53) in the null industry is somewhat better than the same rating for PPTDF (100). This means that CPMV’s stock grew somewhat faster than PPTDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPMVPPTDF
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
39%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
21%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
40%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
28%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
29%
Advances
ODDS (%)
Bullish Trend 4 days ago
63%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CPMV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PPTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VPADX108.75N/A
N/A
Vanguard Pacific Stock Index Admiral
RYECX200.77N/A
N/A
Rydex Energy C
LAVYX17.15N/A
N/A
Lord Abbett Fundamental Equity I
PQIPX13.92N/A
N/A
PIMCO Dividend and Income I2
AMTAX10.40N/A
N/A
AB All Market Real Return A

CPMV and

Correlation & Price change

A.I.dvisor tells us that CPMV and RANI have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPMV and RANI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPMV
1D Price
Change %
CPMV100%
-0.01%
RANI - CPMV
23%
Poorly correlated
-2.20%
AKESF - CPMV
22%
Poorly correlated
N/A
PPTDF - CPMV
21%
Poorly correlated
N/A
SIGY - CPMV
6%
Poorly correlated
N/A
HLOSF - CPMV
5%
Poorly correlated
N/A
More

PPTDF and

Correlation & Price change

A.I.dvisor tells us that PPTDF and HOTH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PPTDF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PPTDF
1D Price
Change %
PPTDF100%
N/A
HOTH - PPTDF
31%
Poorly correlated
-7.18%
BGMS - PPTDF
28%
Poorly correlated
-2.07%
IGC - PPTDF
22%
Poorly correlated
-4.38%
LABFF - PPTDF
22%
Poorly correlated
N/A
CPMV - PPTDF
21%
Poorly correlated
-0.01%
More